Alzheimer’s

New diagnostic tool for Alzheimer’s could improve drug trial recruitment

Artificial intelligence has been used to identify network-based links between COVID-19 and Alzheimer’s disease

New Alzheimer’s Drug Data Issues

Modelling Alzheimer’s Disease Progression to Simulate Intervention Strategies

Identifying Alzheimer’s Disease Molecular Subtypes

Zonisamide as a Treatment for Dementia

AlzGPS: A Genome-Wide Positioning Systems Platform for Alzheimer’s Drug Discovery

24 February 2021

Drug repurposing in Alzheimer’s disease

6 November 2020

New artificial intelligence study of Alzheimer’s

6 November 2020

FDA staff back controversial Alzheimer’s drug